| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Sales - EUR | - | - | 3.249 | 12.810 | 17.846 | 15.461 | 32.251 | 34.293 | 33.288 | 32.454 |
| Total Income - EUR | - | - | 3.249 | 12.810 | 17.846 | 15.461 | 32.251 | 34.547 | 33.793 | 32.705 |
| Total Expenses - EUR | - | - | 544 | 45 | 140 | 137 | 143 | 1.252 | 9.088 | 9.288 |
| Gross Profit/Loss - EUR | - | - | 2.705 | 12.765 | 17.706 | 15.323 | 32.108 | 33.294 | 24.705 | 23.418 |
| Net Profit/Loss - EUR | - | - | 2.607 | 12.380 | 17.171 | 14.888 | 31.140 | 32.487 | 24.372 | 22.444 |
| Employees | - | - | 0 | 0 | 0 | 0 | 0 | 1 | 1 | 1 |
Check the financial reports for the company - Coreli Medica Srl
| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Fixed Assets | - | - | 0 | 627 | 538 | 452 | 369 | 1.056 | 474 | 147 |
| Current Assets | - | - | 3.289 | 11.917 | 19.072 | 15.118 | 31.065 | 32.669 | 25.232 | 23.551 |
| Inventories | - | - | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Receivables | - | - | 0 | 0 | 12.164 | 9.961 | 12.959 | 23.388 | 18.379 | 16.760 |
| Cash | - | - | 3.289 | 11.917 | 6.909 | 5.157 | 18.106 | 9.281 | 6.853 | 6.791 |
| Shareholders Funds | - | - | 2.651 | 12.432 | 17.221 | 14.937 | 31.189 | 32.536 | 24.420 | 22.492 |
| Social Capital | - | - | 44 | 43 | 42 | 41 | 40 | 41 | 40 | 40 |
| Debts | - | - | 638 | 112 | 2.389 | 633 | 245 | 429 | 1.032 | 1.205 |
| Income in Advance | - | - | 0 | 0 | 0 | 0 | 0 | 760 | 253 | 0 |
| Exchange rate - RON | 4.9743 | 4.9465 | 4.9315 | 4.9468 | 4.8371 | 4.7454 | 4.6535 | 4.5681 | 4.4908 | 4.445 |
| Main CAEN | "8622 - 8622" | |||||||||
| CAEN Financial Year |
8622
|
|||||||||
Comments - Coreli Medica Srl